Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tomotherapy Inc.
Deal Snapshot: Roche gene therapy subsidiary Spark gets option and will partner with start-up NeuExcell on a Huntington’s gene therapy that researchers say may regenerate functional neurons.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
TNX-1600 joins two other candidates, including Phase III TNX-102 SL, in Tonix’s PTSD portfolio. CureVac and Yale partner on mRNA therapies for pulmonary disease.
- Other Names / Subsidiaries
- Chengdu Twin Peak Accelerator Technology Inc.